Rhemox Forte, 1000 mg/g Powder for Use in Drinking Water for Chickens, Ducks, Turkeys

Pays: Royaume-Uni

Langue: anglais

Source: VMD (Veterinary Medicines Directorate)

Achète-le

Ingrédients actifs:

Amoxicillin Trihydrate

Disponible depuis:

Livisto Int'l S.L.

Code ATC:

QJ01CA04

DCI (Dénomination commune internationale):

Amoxicillin Trihydrate

forme pharmaceutique:

Powder for use in drinking water

Type d'ordonnance:

POM-V - Prescription Only Medicine – Veterinarian

Groupe thérapeutique:

Chickens, Duck, Turkeys

Domaine thérapeutique:

Antimicrobial

Statut de autorisation:

Authorized

Date de l'autorisation:

2016-06-14

Résumé des caractéristiques du produit

                                Revised: July 2021
AN: 01026/2020
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Rhemox Forte, 1000 mg/g Powder for use in Drinking Water for chickens,
ducks,
turkeys
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each g contains:
ACTIVE SUBSTANCE:
Amoxicillin trihydrate
1000 mg
(equivalent to amoxicillin
871.24 mg)
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Powder for use in Drinking Water.
White to off-white powder.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Chickens, ducks, turkeys
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of infections in chickens, ducks and turkeys caused by
bacteria
susceptible to amoxicillin.
4.3
CONTRAINDICATIONS
Do not use in animals with hypersensitivity to penicillins and other
ß-lactam
antibiotics.
Do not use in ruminants and horses and lagomorphs and rodents such as
rabbits,
hamsters, gerbils and guinea pigs.
Do not administer to animals with renal disease including anuria or
oliguria.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: July 2021
AN: 01026/2020
Page 2 of 7
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Official, national and regional antimicrobial policies should be taken
into account
when the product is used.
Use of the product should be based on susceptibility testing of the
bacteria isolated
from the animal. If this is not possible, therapy should be based on
local (regional,
farm level) epidemiological information about susceptibility of the
target bacteria.
Use of the product deviating from the instructions given in the SPC
may increase the
prevalence of bacteria resistant to the amoxicillin and may decrease
the
effectiveness of the treatment.
Special precautions to be taken by the person administering the
veterinary medicinal
product to animals
Penicillins and cephalosporins may cause hypersensitivity (allergy)
following
injection, inhalation, ingestion or skin contact. Hypersensitivity to
penicillins may lead
to cross react
                                
                                Lire le document complet
                                
                            

Rechercher des alertes liées à ce produit